Judge Orders Cancellation of Over 25 Million Adia Nutrition Shares, Bolstering Shareholder Value
Adia Nutrition (OTC Pink: ADIA) has announced a significant court ruling ordering the cancellation of over 25 million shares, including more than 15 million restricted common shares and 10 million preferred shares. This decision will reduce the company's outstanding shares by over 15 million.
The company has already contacted the transfer agent to initiate the share cancellation process. According to CEO Larry Powalisz, this reduction in outstanding shares is expected to increase the value of remaining shares by concentrating ownership and improving earnings per share metrics, directly benefiting current investors.
The company anticipates additional strategic initiatives in the near future as it continues to operate in the nutrition and wellness sector.
Adia Nutrition (OTC Pink: ADIA) ha annunciato una significativa sentenza del tribunale che ordina la cancellazione di oltre 25 milioni di azioni, comprese più di 15 milioni di azioni comuni restrittive e 10 milioni di azioni privilegiate. Questa decisione ridurrà le azioni in circolazione dell'azienda di oltre 15 milioni.
L'azienda ha già contattato l'agente di trasferimento per avviare il processo di cancellazione delle azioni. Secondo il CEO Larry Powalisz, questa riduzione delle azioni in circolazione dovrebbe aumentare il valore delle azioni rimanenti concentrando la proprietà e migliorando i parametri di utili per azione, beneficiando direttamente gli investitori attuali.
L'azienda prevede ulteriori iniziative strategiche nel prossimo futuro mentre continua a operare nel settore della nutrizione e del benessere.
Adia Nutrition (OTC Pink: ADIA) ha anunciado un fallo judicial significativo que ordena la cancelación de más de 25 millones de acciones, incluyendo más de 15 millones de acciones comunes restringidas y 10 millones de acciones preferentes. Esta decisión reducirá las acciones en circulación de la empresa en más de 15 millones.
La empresa ya ha contactado al agente de transferencia para iniciar el proceso de cancelación de acciones. Según el CEO Larry Powalisz, se espera que esta reducción en las acciones en circulación aumente el valor de las acciones restantes al concentrar la propiedad y mejorar los indicadores de ganancias por acción, beneficiando directamente a los inversores actuales.
La empresa anticipa iniciativas estratégicas adicionales en un futuro cercano mientras continúa operando en el sector de nutrición y bienestar.
Adia Nutrition (OTC Pink: ADIA)는 2,500만 주 이상의 주식, 그 중 1,500만 주 이상의 제한된 보통주와 1,000만 주의 우선주를 취소하라는 중요한 법원 판결을 발표했습니다. 이 결정은 회사의 유통 주식을 1,500만 주 이상 줄이는 결과를 가져올 것입니다.
회사는 이미 주식 취소 프로세스를 시작하기 위해 이전 에이전트에 연락했습니다. CEO인 래리 포왈리츠에 따르면, 유통 주식의 감소는 소유권을 집중시키고 주당 순이익 지표를 개선함으로써 남아 있는 주식의 가치를 증가시킬 것으로 예상되며, 이는 현재 투자자들에게 직접적인 혜택을 줄 것입니다.
회사는 앞으로도 영양 및 웰니스 분야에서 계속 운영하면서 추가적인 전략적 이니셔티브를 계획하고 있습니다.
Adia Nutrition (OTC Pink: ADIA) a annoncé un jugement judiciaire significatif ordonnant l'annulation de plus de 25 millions d'actions, dont plus de 15 millions d'actions ordinaires restreintes et 10 millions d'actions privilégiées. Cette décision réduira le nombre d'actions en circulation de l'entreprise de plus de 15 millions.
L'entreprise a déjà contacté l'agent de transfert pour initier le processus d'annulation des actions. Selon le PDG Larry Powalisz, cette réduction des actions en circulation devrait augmenter la valeur des actions restantes en concentrant la propriété et en améliorant les indicateurs de bénéfice par action, bénéficiant directement aux investisseurs actuels.
L'entreprise prévoit des initiatives stratégiques supplémentaires dans un avenir proche alors qu'elle continue d'opérer dans le secteur de la nutrition et du bien-être.
Adia Nutrition (OTC Pink: ADIA) hat ein bedeutendes Gerichtsurteil bekannt gegeben, das die Streichung von über 25 Millionen Aktien anordnet, darunter mehr als 15 Millionen eingeschränkte Stammaktien und 10 Millionen Vorzugsaktien. Diese Entscheidung wird die ausstehenden Aktien des Unternehmens um über 15 Millionen reduzieren.
Das Unternehmen hat bereits den Übertragungsagenten kontaktiert, um den Prozess der Aktienstreichung einzuleiten. Laut CEO Larry Powalisz wird diese Reduzierung der ausstehenden Aktien voraussichtlich den Wert der verbleibenden Aktien erhöhen, indem sie das Eigentum konzentriert und die Kennzahlen des Gewinns pro Aktie verbessert, was den aktuellen Investoren direkt zugutekommt.
Das Unternehmen erwartet in naher Zukunft weitere strategische Initiativen, während es weiterhin im Bereich Ernährung und Wellness tätig ist.
- Court-ordered cancellation of over 25 million shares (15M restricted common + 10M preferred)
- 15% reduction in outstanding shares
- Expected increase in per-share value through ownership concentration
- Potential improvement in earnings per share metrics
- None.
Winter Park, Florida--(Newsfile Corp. - April 1, 2025) - Adia Nutrition (OTC Pink: ADIA), a leader in innovative nutritional solutions, is pleased to announce a significant milestone for its shareholders following a recent court ruling. A judge has ordered the cancellation of over 25 million shares of Adia Nutrition stock, including more than 15 million restricted common shares and 10 million preferred shares. This landmark decision will reduce the company's outstanding shares by over 15 million, with Adia Nutrition having already contacted the transfer agent to initiate the share cancellation process, marking a pivotal step in enhancing shareholder value.
Adia Nutrition Share Structure Before Cancellation
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/246724_share_strcuture_b4_cancellation.jpeg
The cancellation of these shares—comprising over 15 million restricted shares and 10 million preferred shares—reflects Adia Nutrition's commitment to optimizing its capital structure. This reduction in outstanding shares is expected to increase the value of remaining shares by concentrating ownership and improving earnings per share metrics, directly benefiting current investors.
"This ruling is a win for our shareholders," said Larry Powalisz, CEO of Adia Nutrition. "By reducing the total number of outstanding shares, we're strengthening the company's financial foundation and enhancing the value of each share held by our loyal investors. This is just the beginning of our efforts to deliver long-term growth and stability."
Adia Nutrition anticipates further strategic initiatives in the near future, signaling that more positive developments are on the horizon. The company remains dedicated to transparency and maximizing shareholder returns as it continues to innovate in the nutrition and wellness sector.
For questions, inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/246724
FAQ
How many shares will be cancelled from Adia Nutrition's (ADIA) stock?
What is the expected impact of ADIA's share cancellation on stockholder value?
When will Adia Nutrition (ADIA) complete the share cancellation process?
What percentage of Adia Nutrition's (ADIA) outstanding shares will be reduced?
